`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`ACRUX DDS PTY LTD. & ACRUX LIMITED
`Petitioners,
`
`v.
`
`KAKEN PHARMACEUTICAL CO., LTD. and VALEANT
`PHARMACEUTICALS INTERNATIONAL, INC.,
`Patent Owner and Licensee
`
`
`
`Case: IPR2017-00190
`U.S. Patent No. 7,214,506
`
`
`
`
`DECLARATION OF LISA N. PHILLIPS
`IN SUPPORT OF PETITIONERS’ UNOPPOSED MOTION
`FOR PRO HAC VICE ADMISSION
`
`
`
`
`
`
`
`
`
`Case IPR2017-00190
`Patent No. 7,214,506
`
`I, Lisa N. Phillips, declare the following:
`
`1.
`
`I am a Partner with the law firm of Rothwell, Figg, Ernst & Manbeck,
`
`P.C., in Washington, DC.
`
`2.
`
`I am a member in good standing of the Pennsylvania Bar. My
`
`Pennsylvania Bar member number is 86728.
`
`3.
`
`I am also a member in good standing of the District of Columbia Bar.
`
`My District of Columbia Bar member number is 485943.
`
`4.
`
`I have not been suspended or disbarred from practice before any court
`
`or administrative body.
`
`5.
`
`I have never had a court or administrative body deny my application
`
`for admission to practice.
`
`6.
`
`I have not applied to appear pro hac vice before any other Patent Trial
`
`and Appeal Board (“Board”) or United States Patent and Trademark Office
`
`(“USPTO”) proceeding over the last three years.
`
`7.
`
`I have never had any court or administrative body impose sanctions or
`
`contempt citations against me.
`
`8.
`
`I have read and will comply with the Office Patent Trial Practice
`
`Guide and the Board’s Rules of Practice for Trials, as set forth in Part 42 of Title
`
`37 of the Code of Federal Regulations.
`
`
`
`2
`
`
`
`Case IPR2017-00190
`Patent No. 7,214,506
`
`9.
`
`I agree to be subject to the United States Patent and Trademark Office
`
`Code of Professional Responsibility set forth in 37 C.F.R. §§ 10.20 et seq., Rules
`
`of Professional Conduct set forth in 37 C.F.R. §§ 11.101 et seq., and disciplinary
`
`jurisdiction under 37 C.F.R. § 11.19(a). I also agree to be subject to the USPTO
`
`Rules of Professional Conduct as set forth in Changes to Representation of Others
`
`Before the United States Patent and Trademark Office; Final Rule, 78 Fed. Reg.
`
`20180 (Apr. 3, 2013) (effective May 3, 2013).
`
`10.
`
`I am an experienced litigation attorney with extensive experience with
`
`issues related to pharmaceutical matters, such as the subject matter of the patent at
`
`issue, U.S. Patent No. 7,214,506 (“the ’506 patent”). I have extensive experience in
`
`many patent infringement litigations in federal district courts, including experience
`
`with fact and expert document and deposition discovery, claim construction,
`
`Markman hearings, motion practice, trials, and hearings.
`
`11.
`
`I am familiar with the subject matter at issue in this proceeding,
`
`including the ’506 patent. I have reviewed the patent and its prosecution history. I
`
`have reviewed the prior art, including, specifically, the asserted references. In
`
`addition, during preparation of the Petition, I worked closely with Petitioners’
`
`counsel of record to draft and finalize the Petition and assisted in the preparation of
`
`Dr. Walters’ expert declaration. I have also reviewed and am familiar with the
`
`
`
`3
`
`
`
`Case IPR2017-00190
`Patent No. 7,214,506
`
`other documents filed in this proceeding. I have knowledge of the technical issues
`
`that are relevant to this proceeding.
`
`12.
`
`I hereby declare that all statements herein of my own knowledge are
`
`true and, further, that these statements are made with the knowledge that willful
`
`false statements and the like are punishable by fine, imprisonment, or both, under
`
`Section 1001 of Title 18 of the United States Code.
`
`
`
`Date: August 23, 2017
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`By: /Lisa N. Phillips/
`Lisa N. Phillips
`ROTHWELL, FIGG, ERNST & MANBECK, P.C.
`607 14th St., N.W., Suite 800
`Washington, DC 20005
`Phone: 202-783-6040
`Fax: 202-783-6031
`
`
`
`
`
`
`4
`
`